Steroid Sulfatase Expression in Ovarian Clear Cell Adenocarcinoma: Immunohistochemical Study

By Okuda T.   Saito H.   Sekizawa A.   Shimizu Y.   Akamatsu T.   Kushima M.   Yanaihara T.   Okai T.   Farina A.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 427-434

Elsevier

Access to resources Recommend Favorite

Splenic metastasis of ovarian clear cell adenocarcinoma: A case report and review of the literature

By Lv Meiling   Li Yuyao   Luo Changqin   Liu Peijun   Yang Jin  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-04 ,pp. : 982-986

Spandidos Publications

Access to resources Recommend Favorite

Hypercalcemia Due to Parathyroid Hormone-Related Protein Produced by Primary Ovarian Clear Cell Adenocarcinoma: Case Report

By Tsunematsu R.   Saito T.   Iguchi H.   Fukuda T.   Tsukamoto N.  

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 218-222

Elsevier

Access to resources Recommend Favorite

CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma

By Miyake Takahito   Ueda Yutaka   Matsuzaki Shinya   Miyatake Takashi   Yoshino Kiyoshi   Fujita Masami   Nomura Taisei   Enomoto Takayuki   Kimura Tadashi  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

By                

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1017-1022

Spandidos Publications

Access to resources Recommend Favorite